Xenis Medical earned the FDA’s 510(k) clearance for the Riva posterior fixation system and launched the device, according to a June 2 news release.
The system has a modular design and tulip head and screw shank options to address complex spinal anatomy and construct challenges. It features a single-step head attachment and removal mechanism, allowing surgeons to attach and detach the tulip head with straightforward instrumentation.
Xenix Medical is working to integrate its proprietary NanoACTIV surface technology in to the Riva system.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
